Skip to main content

Table 1 Baseline characteristics in both study groups.

From: The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial

 

Control group

Tα1 group

P value

n

180

181

 

Age (yr)

66.4 ± 12.6

64.7 ± 14.5

0.46

Age group

  

0.79

   < 50 yr

21 (11.7%)

24 (13.3%)

 

   50-60 yr

39 (21.7%)

45 (24.9%)

 

   61-70 yr

39 (21.7%)

39 (21.6%)

 

   71-yr

81 (45.0%)

73 (40.3%)

 

Male

131 (72.8%)

141 (77.9%)

0.26

Female

49 (27.2%)

40 (22.1%)

 

BMI

22.0 ± 3.0

22.2 ± 3.1

0.48

Prior or preexisting conditions

   Congestive heart failure

8 (4.4%)

5 (2.8%)

0.39

   Hypertension

79 (43.9%)

80 (44.2%)

0.95

   Coronary heart disease

19 (10.6%)

22 (12.2%)

0.63

   Liver disease

10 (5.6%)

9 (5.0%)

0.80

   COPD

28 (15.6%)

29 (16.0%)

0.90

   Nervous system diseases

33 (18.3%)

32 (17.7%)

0.87

   Diabetes

34 (18.9%)

40 (22.1%)

0.45

   Recent trauma

8 (4.4%)

8 (4.4%)

0.99

   Cancer

55 (30.6%)

60 (33.2%)

0.60

Recent surgical history

  

0.47

   No history of surgery

103 (57.2%)

92 (50.8%)

 

   Elective surgery

41 (22.8%)

46 (25.4%)

 

   Emergency surgery

36 (20.0%)

43 (23.8%)

 

Other indicators of disease severity

   Mechanical ventilation

143 (79.4%)

146 (80.7%)

0.77

   Shock

74 (41.1%)

64(35.4%)

0.26

   Use of any vasopressor or dobutamine

72 (40.0%)

71(39.2%)

0.88

   Low-dose corticoid

18 (10.0%)

20 (11.1%)

0.75

   Blood transfusion

54 (30.0%)

64 (35.4%)

0.28

Baseline acute organ dysfunctions

   

   Pulmonary

170 (94.4%)

172 (95.0%)

0.80

   Renal

48 (26.7%)

53 (29.3%)

0.58

   Cardiovascular

113 (62.8%)

124 (68.5%)

0.25

   Hematologic

69 (38.3%)

67 (37.0%)

0.80

   Hepatic

39 (21.7%)

27 (14.9%)

0.10

Number of acute organ dysfunction

  

0.97

   1

32 (17.8%)

29 (16.0%)

 

   2

75 (41.7%)

77 (42.5%)

 

   3

45 (25.0%)

48 (26.5%)

 

   4

18 (10.0%)

19 (10.5%)

 

   5

10 (5.6%)

8 (4.4%)

 

APACHE II score

21.6 ± 7.7

22.3 ± 6.7

0.35

SOFA score

7.7 ± 3.9

7.9 ± 3.6

0.65

   Respiratory system

2.6 ± 1.0

2.7 ± 0.9

0.22

   Coagulation

0.8 ± 1.1

1.0 ± 1.2

0.17

   Cardiovascular system

1.4 ± 1.6

1.2 ± 1.5

0.40

   Liver

0.6 ± 0.9

0.5 ± 0.8

0.38

   Nervous system

1.3 ± 1.4

1.4 ± 1.4

0.69

   Renal system

1.0 ± 1.3

1.0 ± 1.4

0.85

Time from first organ dysfunction to enrollment (hr) median(IQR)

28.0 (15.0-48.0)

42.0 (24.0-72.0)

0.003

  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; BMI, body mass index; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; SOFA, Sequential Organ Failure Assessment; Tα1, thymosin alpha 1; yr, year.